← Research library

Novel Peptidomimetic Cyclo-{E(I)-E(W)}Na (CP-88) with Hematopoietic Activity Sustained in Invasive and Oral Administration: Experimental and Preclinical Evaluation

Animal research · 2024

What was studied
Source-specific experimental population
Main finding
Mouse and laboratory experiments report colony-forming activity, CD34-positive-cell changes and NF-κB reporter activation. These do not establish long-term stem-cell self-renewal, direct Toll-like-receptor binding or a causal NF-κB mechanism. Oral experimental activity does not establish human pharmacokinetics; preclinical safety extrapolations are not safe human doses.

Intact-mouse spleen colony formation · Control 14.5±1.6 colonies per 100,000 cells; CP-88 injected 19.9±1.3, oral 19.3±1.3; both marked p<0.05 versus control.

Reported findings and study design

Population or model Source-specific experimental population

Results · Original full-text XML; Table 1 and reporting limitations in Tables 2–3
MeasureResultComparison, timing and statistics
Intact-mouse spleen colony formationControl 14.5±1.6 colonies per 100,000 cells; CP-88 injected 19.9±1.3, oral 19.3±1.3; both marked p<0.05 versus control.
Stemokin in the same table14.7±0.7 injected and 14.3±1.8 oral; neither carries a significance mark.

No CP-88-versus-Stemokin significance is established by separate control tests. Table 2 footnotes and Table 3 marker/header labels need clarification. Colony formation does not establish long-term stem-cell self-renewal or human benefit.

Source for these results ↗ · Reviewed 2026-11-06

Study limitations and source details

Study limitations

  • Independent replication and full risk-of-bias appraisal remain unresolved.
  • No personalized treatment or safety conclusion follows from this record.

Source details

Original full text retrieved from Europe PMC; experimental scope and interpretation checked. Supplementary methods and independent replication remain review targets.

Original XML; Table 1 extracted, Tables 2–3 reporting ambiguities flagged

Sources checked

Citation

Animal / experimentalFull text available

Vladislav Deigin, Yulia Vinogradova, Dmitriy Vinogradov, Natalia Linkova, Anastasiia Dyatlova, Dmitrii Medvedev, Alexander Krasichkov, Victoria Polyakova. Novel Peptidomimetic Cyclo-{E(I)-E(W)}Na (CP-88) with Hematopoietic Activity Sustained in Invasive and Oral Administration: Experimental and Preclinical Evaluation International Journal of Molecular Sciences 25(24):13385

Study source ↗ · DOI 10.3390/ijms252413385 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards